Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Daily deal net: September 20, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.


Sep 20, 2021

GUV Awards 2021 nominees

Global University Venturing will reveal the winners of this year's awards at the gala dinner as part of the GCV Symposium on November 3.

Sep 20, 2021

Wrnch pulls off acquisition

Hinge Health has bought Wrnch, a computer vision technology developer exploiting research from Concordia University.

Sep 20, 2021

Inpria processes $514m acquisition

Oregon State University spinout Inpria has agreed to a purchase by its existing shareholder JSR and will become a subsidiary of the petrochemical company.

Sep 20, 2021

Australian Ethical adds to Main Sequence fund

The investment manager has become a limited partner in CSIRO-founded Main Sequence Ventures, which announced its $194m Fund 2 in April this year.

Sep 20, 2021

Prenetics tests out $1.25bn reverse merger

Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.

Sep 17, 2021

Hydrogenious LOHC fuels up on funding

Erlangen-Nürnberg spinout Hydrogenious LOHC Technologies has added $59m to its coffers.

Sep 17, 2021

EnerVenue electrifies $100m series A

Stanford University has backed a round that will help the nickel-hydrogen battery developer finance construction of a Gigafactory.

Sep 17, 2021

Daily deal net: September 15, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 15, 2021

Louisville launches UofL Ventures

Will Metcalf will lead the office, which will be located within University of Louisville’s Office of Research and Innovation.

Sep 15, 2021

Context Therapeutics frames IPO plans

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.

Sep 15, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here